Water → 5-chloro-3-[3-(5-methyl-1,2,4-oxadiazol-3-yl)benzyl]-3H-benzothiazol-2-one

HRID 330807Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 330807
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[S:9][C:8](=[O:10])[NH:7][C:6]=2[CH:11]=1.Br[CH2:13][C:14]1[CH:15]=[C:16]([C:20]2[N:24]=[C:23]([CH3:25])[O:22][N:21]=2)[CH:17]=[CH:18][CH:19]=1.C(=O)([O-])[O-].[K+].[K+].O>C(#N)C>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[S:9][C:8](=[O:10])[N:7]([CH2:13][C:14]3[CH:19]=[CH:18][CH:17]=[C:16]([C:20]4[N:24]=[C:23]([CH3:25])[O:22][N:21]=4)[CH:15]=3)[C:6]=2[CH:11]=1

Komponenten

6

Reaktionsbedingungen

Temperatur
80 °C

Versuchsvorschrift

A suspension of 100 mg (0.54 mmol) of 5-chloro-3H-benzothiazol-2-one, 153 mg (0.59 mmol) of 3-(3-bromomethylphenyl)-5-methyl-1,2,4-oxadiazole and 303 mg (2.16 mmol) of potassium carbonate in 20 ml of acetonitrile are stirred at 80° C. for 1 h. 30 ml of water are added to the reaction mixture, which is then extracted with MTBE, dried and evaporated to dryness. The crude product is purified by column chromatography on silica gel and stirred with ether, giving “A12”: ESI: 358 (M+H); Rt.=3.25 min (method A);

Aufarbeitung

  1. extractionis then extracted with MTBE
  2. customdried
  3. customevaporated to dryness
  4. customThe crude product is purified by column chromatography on silica gel
  5. stirringstirred with ether
  6. customgiving “A12”
  7. custom=3.25 min (method A)

Quellen und Nachweise

ORD-Eintrag
ord-f09265ae30754b2eadccc6f75fc240fa
Quelldatensatz
uspto-grants-2014_11
Patentnummer
US08877751B2

Notizen zur Reaktion

Wird geladen…